These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8088895)

  • 21. Bacterial-induced RBC alterations complicating necrotizing enterocolitis.
    Novak RW
    Am J Dis Child; 1984 Feb; 138(2):183-5. PubMed ID: 6695876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-associated carbohydrate antigens: Sialyl Lea and T/Tn antigens in canine mammary tumors.
    Nowak M; Madej J; Dziegiel P; Lopuszynski W; Rodo A; Ugorski M
    Vet Pathol; 2009 Mar; 46(2):222-6. PubMed ID: 19261632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemolytic-uraemic syndrome and T-activation of red blood cells.
    Hamilton DV; Black AJ; Darnborough J; Bird GW
    Clin Lab Haematol; 1983; 5(1):109-12. PubMed ID: 6851433
    [No Abstract]   [Full Text] [Related]  

  • 24. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IgG-mediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the newborn?
    Brinc D; Le-Tien H; Crow AR; Freedman J; Lazarus AH
    Br J Haematol; 2007 Oct; 139(2):275-9. PubMed ID: 17897303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth, efficacy, and safety of feeding an iron-fortified human milk fortifier.
    Berseth CL; Van Aerde JE; Gross S; Stolz SI; Harris CL; Hansen JW
    Pediatrics; 2004 Dec; 114(6):e699-706. PubMed ID: 15545616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythrocyte t activation.
    Bibbing J; Favara BE
    Rocky Mt Med J; 1977; 74(5):259-61. PubMed ID: 910098
    [No Abstract]   [Full Text] [Related]  

  • 28. [Flow cytometry detection of erythrocyte antigens and antibodies. Technical aspects and new clinical applications].
    Fischer K; Wester S; Grundmann A; Poschmann A
    Infusionsther Transfusionsmed; 1995 Dec; 22(6):344-9. PubMed ID: 8589594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T-antigen activation for prediction of pneumococcus-induced hemolytic uremic syndrome and hemolytic anemia.
    Huang DT; Chi H; Lee HC; Chiu NC; Huang FY
    Pediatr Infect Dis J; 2006 Jul; 25(7):608-10. PubMed ID: 16804430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-cryptantigen (TCA) activation in sever pneumonia complicated with multiple organ failure.
    Wang Q; Liu D; Bai Y
    Transfus Apher Sci; 2010 Dec; 43(3):361-364. PubMed ID: 21075688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of the erythrophagocytosis assay for predicting the clinical consequences of immune blood cell destruction.
    Biondi CS; Cotorruelo CM; Ensinck A; Racca LL; Racca AL
    Clin Lab; 2004; 50(5-6):265-70. PubMed ID: 15209434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gel agglutination test--a new test system for semiquantitative detection of feto-maternal transfusion in Rhesus incompatibility].
    David M; Stelzer A; Wittmann G; Dudenhausen JW; Salama A
    Z Geburtshilfe Neonatol; 1999; 203(6):241-5. PubMed ID: 10612196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of blood group A and B antigens in human glycophorin.
    Podbielska M; Krotkiewski H
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):211-21. PubMed ID: 10912628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [T antigen test of sputum--a new simple method for the screening of lung cancer].
    Li X; Dai X; He A
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Oct; 18(5):285-6, 317. PubMed ID: 8762480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transfusional therapy of hemodialyzed patient with anti-Cartwright antibodies: case report and review of the literature].
    Franchini M; Fabbian F; Piccoli PL; Gandini G; Aprili G; Loschiavo C; Lupo A
    G Ital Nefrol; 2004; 21(4):387-90. PubMed ID: 15526404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histo-blood group antigens as allo- and autoantigens.
    Nydegger UE; Tevaearai H; Berdat P; Rieben R; Carrel T; Mohacsi P; Flegel WA
    Ann N Y Acad Sci; 2005 Jun; 1050():40-51. PubMed ID: 16014519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of anti-erythrocyte autoantibodies in non-Hodgkin's lymphoma patients in Brazil.
    Barjas de Castro ML; Locatelli MF; de Castilho LM; de Souza CA
    Haematologia (Budap); 1998; 29(2):139-45. PubMed ID: 9728806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells.
    Hendrickson JE; Desmarets M; Deshpande SS; Chadwick TE; Hillyer CD; Roback JD; Zimring JC
    Transfusion; 2006 Sep; 46(9):1526-36. PubMed ID: 16965580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease.
    Ribeiro KR; Guarnieri MH; da Costa DC; Costa FF; Pellegrino J; Castilho L
    Vox Sang; 2009 Aug; 97(2):147-52. PubMed ID: 19392786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of peptides that bind the tumor-associated Thomsen-Friedenreich antigen selected from bacteriophage display libraries.
    Peletskaya EN; Glinsky VV; Glinsky GV; Deutscher SL; Quinn TP
    J Mol Biol; 1997 Jul; 270(3):374-84. PubMed ID: 9237904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.